Cellular Dynamics International (CDI), a FUJIFILM company, is a Wisconsin-based developer and manufacturer of induced pluripotent stem cells (iPSCs) used in drug discovery, toxicity testing, stem cell banking and cell therapy development. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research, of the University of Wisconsin-Madison.
Prior to the company’s acquisition in 2015 by FUJIFILM, CDI came to Russo Partners to help increase visibility for CDI’s cutting-edge technology platform among the investment community and potential customers. CDI was a small company with a complex technology whose long term prospects were illusive to a consumer and investor public. A significant component of the program was leadership positioning for CDI and its technology through the strategic pursuit of award opportunities, including the Edison Award and The Scientist’s Top 10 Innovations. One honor of note was Russo Partners successful nomination of CDI for the Wall Street Journal Technology Innovation Awards: The awards were determined by a panel of independent judges who evaluated significant innovations that occurred in the previous year. Six hundred and five applicants competed for the award in 16 categories. CDI’s iPSC technology took Gold, ahead of IBM’s Watson (link here), reinforcing the company’s value proposition among investors and customers.